PTIX

Protagenic Therapeutics, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/12/2016
Contact Info
  • 149 Fifth Avenue
  • Suite 500
  • New York, NY 10010

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Deregistered a/o Mar 30, 2012
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001022899
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 7389 - Business services, misc
Incorporated In: DE, USA
Year of Inc. 1994
Employees 3 a/o Sep 09, 2016
Company Officers/Contacts
Alexander K. Arrow CFO
Carol Haggerty Administrator
Company Directors
Garo H. Armen Executive Chairman
Khalil Barrage
Gregory Ekizian
Josh Silverman
Robert B. Stein
Company Notes
  • Formerly=Atrinsic, Inc. until 7-2016
  • Formerly=New Motion, Inc. until 6-2009
  • Formerly=MPLC, Inc. until 5-07
  • Formerly=MPLC, Inc. (formerly Millbrook Press Inc. (The)) until 8-06
  • Note=12-5-05 final bankruptcy distribution made to eligible shareholders & company continues to trade as a shell
  • Note=10-20-05 company is a shell, intending to acquire assets or shares of an entitiy in a business that generates revenues
  • Note=2-6-04 company filed petition under Chapter XI of the Federal Bankruptcy Code in the U.S. Bankruptcy Court for the District of Connecticut
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Meister Seelig & Fein LLP
125 Park Avenue
7th Floor
New York, NY, 10017
United States

Investor Relations Firm
Not Available
PTIX Security Details
Share Structure
Market Value1 Not Available
Authorized Shares 100,000,000 a/o Sep 30, 2016
Outstanding Shares 8,307,915 a/o Nov 17, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders
Shareholders of Record 333 a/o Sep 25, 2015
Short Selling Data
Short Interest 1 (0%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security